Feb 5 (Reuters) - AstraZeneca said on Friday its cancer drug Imfinzi did not meet the main goal of improving overall survival in a trial. (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Shounak Dasgupta)
我们的标准: 汤森路透“信任原则”
Feb 5 (Reuters) - AstraZeneca said on Friday its cancer drug Imfinzi did not meet the main goal of improving overall survival in a trial. (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Shounak Dasgupta)
我们的标准: 汤森路透“信任原则”